Literature DB >> 28839822

A guide to midgut neuroendocrine tumours (NETs) and carcinoid syndrome.

Vincent T F Cheung1, Mohid S Khan2.   

Abstract

Patients with midgut neuroendocrine tumours or carcinoid syndrome often face a delayed diagnosis. This article aims to highlight the different ways in which patients with midgut neuroendocrine tumours (NETs) present, the diagnostic approach to them, the current methods of management available and future considerations.

Entities:  

Keywords:  Cancer; Diarrhoea; Liver Metastases; Small Intestine Cancer

Year:  2014        PMID： 28839822      PMCID： PMC5369594          DOI： 10.1136/flgastro-2014-100483

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


  27 in total

Review 1.  Carcinoid tumors.

Authors:  M H Kulke; R J Mayer
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

2.  The classification of carcinoid tum ours.

Authors:  E D WILLIAMS; M SANDLER
Journal:  Lancet       Date:  1963-02-02       Impact factor: 79.321

3.  Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors:  A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal:  Am Heart J       Date:  1954-06       Impact factor: 4.749

4.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; A Couvelard; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

5.  Detection of small-bowel neuroendocrine tumors by video capsule endoscopy.

Authors:  Sebastiaan A C van Tuyl; Jacco Tenthof van Noorden; Robin Timmer; Mark F J Stolk; Ernst J Kuipers; Babs G Taal
Journal:  Gastrointest Endosc       Date:  2006-07       Impact factor: 9.427

6.  Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

Authors:  Irfan Kayani; Jamshed B Bomanji; Ashley Groves; Gerard Conway; Sveto Gacinovic; Thida Win; John Dickson; Martyn Caplin; Peter Joseph Ell
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

7.  Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

Authors:  Siegbert Faiss; Ulrich-Frank Pape; Michael Böhmig; Yvonne Dörffel; Ulrich Mansmann; Werner Golder; Ernst Otto Riecken; Bertram Wiedenmann
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.

Authors:  C Swärd; V Johanson; E Nieveen van Dijkum; S Jansson; O Nilsson; B Wängberg; H Ahlman; L Kölby
Journal:  Br J Surg       Date:  2009-05       Impact factor: 6.939

9.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064
View more
  6 in total

Review 1.  New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Feng Yin; Zi-Hao Wu; Jin-Ping Lai
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

Review 2.  Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.

Authors:  Francesca Spada; Roberta E Rossi; Elda Kara; Alice Laffi; Sara Massironi; Manila Rubino; Franco Grimaldi; Sherrie Bhoori; Nicola Fazio
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-04

Review 3.  The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.

Authors:  Jakub Pobłocki; Anna Jasińska; Anhelli Syrenicz; Elżbieta Andrysiak-Mamos; Małgorzata Szczuko
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

Review 4.  Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome.

Authors:  Dominique Clement; John Ramage; Raj Srirajaskanthan
Journal:  J Oncol       Date:  2020-01-21       Impact factor: 4.375

5.  A case of metastatic neuroendocrine disease and cholecystitis: surgical remedy and management of carcinoid crisis.

Authors:  Phillip J Whiley; Janaka Balasooriya; Rudyard J Wake
Journal:  J Surg Case Rep       Date:  2021-12-11

6.  Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection.

Authors:  Faidon-Marios Laskaratos; Man Liu; Anna Malczewska; Olagunju Ogunbiyi; Jennifer Watkins; Tu Vinh Luong; Dalvinder Mandair; Martyn Caplin; Christos Toumpanakis
Journal:  Endocrine       Date:  2020-04-14       Impact factor: 3.633
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.